As a subtype of breast cancer with complex heterogeneity, TNBC lacks estrogen receptor, progesterone receptor, and human epidermal growth factor receptor expression in the hormone level, which increases the difficulty of treatment (Nedeljkovic and Damjanovic, 2019). Here, ESR1 is linked to breast carcinoma.